Carmen Barile

402 total citations
14 papers, 273 citations indexed

About

Carmen Barile is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Carmen Barile has authored 14 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Rheumatology. Recurrent topics in Carmen Barile's work include Cancer Treatment and Pharmacology (5 papers), Renal cell carcinoma treatment (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Carmen Barile is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Renal cell carcinoma treatment (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Carmen Barile collaborates with scholars based in Italy, Denmark and Hungary. Carmen Barile's co-authors include Felice Pasini, Roberto Padrini, Milena Gusella, Cristina Ghiotto, Antonio Jirillo, Alberto Amadori, Salvatore Pucciarelli, Michele Aieta, Rita Zamarchi and Salvatore Tumolo and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Clinical Pharmacology.

In The Last Decade

Carmen Barile

14 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Barile Italy	8	204	86	76	65	28	14	273
Bastianina Canu Italy	10	197 1.0×	84 1.0×	103 1.4×	136 2.1×	12 0.4×	15	346
Simona Bevilacqua Italy	8	152 0.7×	81 0.9×	78 1.0×	77 1.2×	13 0.5×	10	244
Fenggang Hou China	12	142 0.7×	113 1.3×	64 0.8×	142 2.2×	10 0.4×	23	313
Laura Demurtas Italy	10	235 1.2×	80 0.9×	87 1.1×	112 1.7×	16 0.6×	20	363
Kazuhiro Togasaki Japan	7	169 0.8×	53 0.6×	65 0.9×	44 0.7×	33 1.2×	10	256
Martin Moik Austria	8	164 0.8×	120 1.4×	77 1.0×	55 0.8×	12 0.4×	10	256
Jenna Wheelhouse United States	8	215 1.1×	94 1.1×	69 0.9×	211 3.2×	11 0.4×	9	375
Hongchao Tang China	10	102 0.5×	107 1.2×	49 0.6×	171 2.6×	18 0.6×	25	288
P. Marpicati Italy	10	214 1.0×	73 0.8×	104 1.4×	56 0.9×	13 0.5×	36	323
Hanxiao Chen China	14	199 1.0×	64 0.7×	192 2.5×	111 1.7×	11 0.4×	34	388

Countries citing papers authored by Carmen Barile

Since Specialization

Citations

This map shows the geographic impact of Carmen Barile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Barile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Barile more than expected).

Fields of papers citing papers by Carmen Barile

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Barile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Barile. The network helps show where Carmen Barile may publish in the future.

Co-authorship network of co-authors of Carmen Barile

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Barile. A scholar is included among the top collaborators of Carmen Barile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Barile. Carmen Barile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Maruzzo, Marco, Andrea Zivi, Donata Sartori, et al.. (2022). Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study. Targeted Oncology. 17(4). 467–474. 3 indexed citations

Gusella, Milena, Felice Pasini, Barbara Corso, et al.. (2020). Predicting steady‐state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?. Pharmacology Research & Perspectives. 8(5). e00646–e00646. 7 indexed citations

Pasini, Felice, Carmen Barile, Donatella Caruso, et al.. (2018). Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world. Investigational New Drugs. 36(5). 927–932. 12 indexed citations

Gusella, Milena, Felice Pasini, Donatella Caruso, et al.. (2018). Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms. Cancer Chemotherapy and Pharmacology. 83(3). 493–500. 14 indexed citations

Caffo, Orazio, Re G, Teodoro Sava, et al.. (2015). Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. Future Oncology. 11(6). 965–973. 7 indexed citations

Gusella, Milena, Antonio Bononi, Paola Franceschetti, et al.. (2014). Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old. Cancer Chemotherapy and Pharmacology. 73(3). 517–524. 9 indexed citations

Bononi, Antonio, Alessandro Inno, Carmen Barile, et al.. (2013). The prognostic value of rapid screening tests (RST) in geriatric assessment of patients with cancer over 70.. Journal of Clinical Oncology. 31(15_suppl). 9554–9554. 2 indexed citations

Pasini, Felice, Anna Paola Fraccon, Carmen Barile, et al.. (2013). Targeted therapies (TT) in metastatic renal cell carcinoma (mRCC): An Italian survey of 902 pts.. Journal of Clinical Oncology. 31(15_suppl). e15514–e15514. 1 indexed citations

Caffo, Orazio, Re G, Teodoro Sava, et al.. (2012). Factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (D) with or without estramustine (E) as first-line treatment for castration-resistant prostate cancer (CRPC): Preliminary results of HOPLITE trial.. Journal of Clinical Oncology. 30(15_suppl). e15160–e15160. 1 indexed citations

10.

Afzal, Shoaib, Milena Gusella, Ben Vainer, et al.. (2011). Combinations of Polymorphisms in Genes Involved in the 5-Fluorouracil Metabolism Pathway Are Associated with Gastrointestinal Toxicity in Chemotherapy-Treated Colorectal Cancer Patients. Clinical Cancer Research. 17(11). 3822–3829. 48 indexed citations

11.

Afzal, Shoaib, Milena Gusella, Ben Vainer, et al.. (2011). The Association of Polymorphisms in 5-Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal Cancer. Pharmacogenomics. 12(9). 1257–1267. 26 indexed citations

12.

Gusella, Milena, Felice Pasini, Carmen Barile, et al.. (2010). Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. British Journal of Clinical Pharmacology. 71(3). 437–444. 20 indexed citations

13.

Rossi, Elisabetta, Umberto Basso, Salvatore Pucciarelli, et al.. (2010). M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis. Clinical Cancer Research. 16(21). 5233–5243. 104 indexed citations

14.

Tagliaferri, Pierosandro, Carmen Barile, Michele Caraglia, et al.. (1998). Daily Low-Dose Subcutaneous Recombinant Interleukin-2 by Alternate Weekly Administration. American Journal of Clinical Oncology. 21(1). 48–53. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact